HLS Therapeutics, Inc. (HLS.TO)

4.59 +0.04 (+0.88%) CAD  |  TSX  |  May 29, 16:00
More

HLS Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for HLS.TO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Bausch Health Cos., Inc. Upgrade
Cipher Pharmaceuticals, Inc. Upgrade
BioSyent, Inc. Upgrade
Revive Therapeutics Ltd. Upgrade
Knight Therapeutics, Inc. Upgrade